GSK plc announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved an updated indication for Shingrix (Recombinant Zoster Vaccine, Adjuvanted - RZV) for the prevention of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback